Literature DB >> 15783241

Vitex agnus castus: a systematic review of adverse events.

Claudia Daniele1, Joanna Thompson Coon, Max H Pittler, Edzard Ernst.   

Abstract

Vitex agnus castus L. (VAC) [Verbenaceae] is a deciduous shrub that is native to Mediterranean Europe and Central Asia. Traditionally, VAC fruit extract has been used in the treatment of many female conditions, including menstrual disorders (amenorrhoea, dysmenorrhoea), premenstrual syndrome (PMS), corpus luteum insufficiency, hyperprolactinaemia, infertility, acne, menopause and disrupted lactation. The German Commission E has approved the use of VAC for irregularities of the menstrual cycle, premenstrual disturbances and mastodynia. Clinical reviews are available for the efficacy of VAC in PMS, cycle disorders, hyperprolactinaemia and mastalgia, but so far no systematic review has been published on adverse events or drug interactions associated with VAC. Therefore, this review was conducted to evaluate all the available human safety data of VAC monopreparations. Literature searches were conducted in six electronic databases, in references lists of all identified papers and in departmental files. Data from spontaneous reporting schemes of the WHO and national drug safety bodies were also included. Twelve manufacturers of VAC-containing preparations and five herbalist organisations were contacted for additional information. No language restrictions were imposed. Combination preparations including VAC or homeopathic preparations of VAC were excluded. Data extraction of key data from all articles reporting adverse events or interactions was performed independently by at least two reviewers, regardless of study design. Data from clinical trials, postmarketing surveillance studies, surveys, spontaneous reporting schemes, manufacturers and herbalist organisations indicate that the adverse events following VAC treatment are mild and reversible. The most frequent adverse events are nausea, headache, gastrointestinal disturbances, menstrual disorders, acne, pruritus and erythematous rash. No drug interactions were reported. Use of VAC should be avoided during pregnancy or lactation. Theoretically, VAC might also interfere with dopaminergic antagonists. Although further rigorous studies are needed to assess the safety of VAC, the data available seem to indicate that VAC is a safe herbal medicine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15783241     DOI: 10.2165/00002018-200528040-00004

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  27 in total

1.  [Use of plant substances in the therapy of menstruation & bleeding disorders & other endocrine diseases of women].

Authors:  W BLEIER
Journal:  Zentralbl Gynakol       Date:  1959-05-02

2.  [Treatment of insufficiency of corpus luteum in general practice].

Authors:  O A ROTH
Journal:  Med Klin       Date:  1956-07-27

3.  Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies.

Authors:  J Barnes; S Y Mills; N C Abbot; M Willoughby; E Ernst
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

4.  The effects of a special Agnus castus extract (BP1095E1) on prolactin secretion in healthy male subjects.

Authors:  P G Merz; C Gorkow; A Schrödter; S Rietbrock; C Sieder; D Loew; J S Dericks-Tan; H D Taubert
Journal:  Exp Clin Endocrinol Diabetes       Date:  1996       Impact factor: 2.949

5.  Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study.

Authors:  R Schellenberg
Journal:  BMJ       Date:  2001-01-20

6.  [Improvement of acne vulgaris following therapy with agnus castus (Agnolyt)].

Authors:  W Amann
Journal:  Ther Ggw       Date:  1967-01

7.  Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS).

Authors:  D Berger; W Schaffner; E Schrader; B Meier; A Brattström
Journal:  Arch Gynecol Obstet       Date:  2000-11       Impact factor: 2.344

Review 8.  Diagnosis and management of hyperprolactinemia.

Authors:  Omar Serri; Constance L Chik; Ehud Ur; Shereen Ezzat
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262

9.  [Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study].

Authors:  A Milewicz; E Gejdel; H Sworen; K Sienkiewicz; J Jedrzejak; T Teucher; H Schmitz
Journal:  Arzneimittelforschung       Date:  1993-07

10.  [Amenorrhea. Favorable effect of Agnus castus (Agnolyt) on amenorrhea].

Authors:  W Amann
Journal:  ZFA (Stuttgart)       Date:  1982-02-10
View more
  17 in total

1.  Maturation of the adrenal medulla--IV. Effects of morphine.

Authors:  T R Anderson; T A Slotkin
Journal:  Biochem Pharmacol       Date:  1975-08-15       Impact factor: 5.858

Review 2.  Adverse effects of plant food supplements and botanical preparations: a systematic review with critical evaluation of causality.

Authors:  Chiara Di Lorenzo; Alessandro Ceschi; Hugo Kupferschmidt; Saskia Lüde; Elizabeth De Souza Nascimento; Ariana Dos Santos; Francesca Colombo; Gianfranco Frigerio; Karin Nørby; Jenny Plumb; Paul Finglas; Patrizia Restani
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

Review 3.  Vitex negundo and its medicinal value.

Authors:  Balraj Singh Gill; Richa Mehra; Sanjeev Kumar
Journal:  Mol Biol Rep       Date:  2018-10-11       Impact factor: 2.316

Review 4.  Botanicals and Their Bioactive Phytochemicals for Women's Health.

Authors:  Birgit M Dietz; Atieh Hajirahimkhan; Tareisha L Dunlap; Judy L Bolton
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

5.  High-content screening and mechanism-based evaluation of estrogenic botanical extracts.

Authors:  Cassia R Overk; Ping Yao; Shaonong Chen; Shixing Deng; Ayano Imai; Matthew Main; Andreas Schinkovitz; Norman R Farnsworth; Guido F Pauli; Judy L Bolton
Journal:  Comb Chem High Throughput Screen       Date:  2008-05       Impact factor: 1.339

6.  A molecular docking study of phytochemical estrogen mimics from dietary herbal supplements.

Authors:  Chelsea N Powers; William N Setzer
Journal:  In Silico Pharmacol       Date:  2015-03-22

7.  Wound healing potentials of Thevetia peruviana: Antioxidants and inflammatory markers criteria.

Authors:  Nazneen Rahman; Haseebur Rahman; Mir Haris; Riaz Mahmood
Journal:  J Tradit Complement Med       Date:  2017-02-14

8.  An update on plant derived anti-androgens.

Authors:  Paul Grant; Shamin Ramasamy
Journal:  Int J Endocrinol Metab       Date:  2012-04-20

9.  Can Vitex Agnus Castus be Used for the Treatment of Mastalgia? What is the Current Evidence?

Authors:  A R Carmichael
Journal:  Evid Based Complement Alternat Med       Date:  2008-09       Impact factor: 2.629

Review 10.  The genus Vitex: A review.

Authors:  Anita Rani; Anupam Sharma
Journal:  Pharmacogn Rev       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.